ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in metastatic prostate cancer
ASCO GU 2026: Updates in localised prostate cancer
Tepotinib in second line NSCLC treatment
Liquid biopsies as translational tools for advancing cancer immunotherapy in Africa
Current state of cancer genomics in Africa
Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer
Improving African representation in breast cancer genomics
Integrating oncogenetics testing into African clinics and cancer control programs
African Oncogenetics Network: improving training and infrastructure in low-resource regions
Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network
The aims of the African Oncogenetics Network
Mismatching of unrelated donors beyond a single HLA-locus does not adversely impact outcomes following transplantation